Jaihind Synthetics Ltd

Certificate submission details

• Certificate under Reg 74(5) for quarter ended Sep 30, 2026 received from Skyline Financial Services Pvt. Ltd.
• No processing details on dematerialisation/rematerialisation are disclosed in this filing chunk.
• Submitted by Jaihind Industries via Registrar Skyline Financial Services Pvt. Ltd.

Jaihind Industries Limited - Trading Window closed from Oct 01, 2026 until 48 hours after the declaration of the Un-Audited Financial Results for the Second quarter ended September 30, 2026

Annual Report distribution

• Annual Report FY2025-26 and AGM notice sent electronically to members with registered emails.
• Web-link to access the full Annual Report and AGM notice provided.
• Email-registration cut-off date: 11 September 2026.
• Members without registered emails should update addresses; demat holders to update with DP/RTA.
• Soft copy hosted on CDSIL and BSE websites.

39th AGM details

• AGM on 11 October 2026 at 9:30 AM IST.
• Venue: registered office at 103 Shreenath Sai Darshan CHS, Borivali East, Mumbai.
• Notice and annual report to be circulated electronically per regulations.
• Record-date cut-off for email updates: 11 September 2026.
• Folio No / DPID-Client Id to be quoted in communications.

Financials FY2025-26

• Total income stood at 19.92 Lakhs; revenue from operations nil.
• Profit after tax: 1.84 Lakhs vs 1.58 Lakhs prior year.
• EPS (basic/diluted): 0.03; no significant change.
• Dividend declared or recommended for the year: none.

Capital structure

• Authorised capital increased to Rs 30 crore; Clause V amended.
• Post-reduction paid-up capital: Rs 628.75 Lakhs; 63,20,000 shares.
• NCLT approved capital reduction on 1-Aug-2025; effective shareholding adjusted.
• Name changed to Jaihind Industries Ltd on 5-Feb-2026; listing approved 16-Apr-2026.

Preferential issue plan

• Board approved issue of up to 2,36,48,000 convertible warrants at Rs 42 each.
• Warrants convert into one equity share; floor price per ICDR; aggregate up to Rs 99.32 crore.
• Promoter and non-promoter allottees include multiple entities; detailed list in notice.
• Lock-in for pre-issue holdings: 90 trading days; 18-month exercise window.

Use of proceeds & objects

• Healthcare expansion target up to Rs 65 crore; hospital infra and equipment.
• Textile/trading expansion up to Rs 20 crore; procurement and distribution.
• Working capital up to Rs 10 crore; general corporate purposes.
• Balance for contingency; deploy over ~18 months with +/-10% flexibility.

Business developments

• Post-year-end: 78% stake in Wellness & Medical Oasisz Private Limited acquired.
• Primary operations: healthcare services and textile finishing; expansion via preferential issue.

Corporate governance & board

• Dinesh Doshi, Whole-time Director, passed away on 17-Aug-2026.
• Prasham Kumar Doshi appointed Additional Executive Director on 18-19-Aug-2026.
• MD appointment for five years from 19-Aug-2026; remuneration up to Rs 3.6 million.
• Pareshkumar Savani to retire by rotation; re-appointment recommended.

Audit & compliance

• Statutory auditors: PSV Jain & Associates; Secretarial auditors: RA Gala & Associates.
• Secretarial audit flagged non-upload of some policies; no internal auditor appointed.
• Independent directors have declarations; Audit Committee meets quarterly.

Risks & segment disclosures

• Single geographic/industry segment; one customer accounts for >10% of revenue.

AGM details

• AGM scheduled for October 11, 2026 at 09:30 IST at the company's registered office.
• Mode: physical meeting with remote e-voting facility.
• Cut-off date for attendance/voting: October 5, 2026.
• Remote e-voting window: October 8–10, 2026.
• Venue: 103, Shreenath Sai Darshan CHS Ltd, Borivali East.

Ordinary resolutions

• Adopt Audited Standalone Financial Statements for year ended March 31, 2026.
• Re-appoint Paresh Savani as Director (retiring by rotation).
• Appoint Prasham Kumar Doshi as Director.
• Appoint Prasham Kumar Doshi as Managing Director for five years.
• Increase authorised share capital and alter MOA Clause V.

Special resolutions

• Approve issue and allotment of Convertible Warrants on a preferential basis.
• Warrants: up to 2,36,48,000, at Rs 42 per warrant.
• Aggregate issue value up to Rs 99.32 crore.
• Objects include healthcare, textiles, working capital, general corporate.
• Floor price determined under SEBI ICDR Regulations.

Director changes

• Prasham Kumar Doshi appointed Director (Additional) on Aug 19, 2026.
• Doshi MD appointment; remuneration up to Rs 36 lakh annually.
• Savani re-appointed as Director.

Preferential warrants update

• Purpose: update to September 11, 2026 announcement on preferential issue of convertible warrants.
• Prasham Kumar Doshi is not eligible; removed from proposed investor list.
• Revised Annexure-I submitted; corrected investor details; no change in size, price, or terms.
• Total proposed warrants: up to 2,36,48,000; price Rs 42 per warrant.
• Warrants exercisable into equity shares; conversion within 18 months from allotment.
• Investor mix: 2 Promoters and 21 Non-Promoters.
• Schedule-A outlines allottee names, counts, price, and consideration.
• Total consideration for allottees: Rs 99,32,16,000.

Capital action: Convertible Warrants

• Approve issue and allotment of up to 2,36,48,000 Convertible Warrants at Rs 42 each, subject to shareholder approval.
• Warrants convertible into one equity share; conversion within 18 months in one or more tranches.
• Recipients: 2 promoters and 22 non-promoters; Schedule A lists allottees.
• Relevant date for preferential issue: Sept 11, 2026.
• Total consideration: Rs 99,32,16,000.
• AGM to approve matter scheduled Oct 11, 2026.